cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
G1 Therapeutics Inc
1 own
1 watching
Current Price
$0
$0.19
(2.33%)
logo-gthx
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
350.04M
52-Week High
52-Week High
17.49
52-Week Low
52-Week Low
3.84
Average Volume
Average Volume
0.49M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
21.333
iconMarket Capitalization350.04M
icon52-Week High17.49
icon52-Week Low3.84
iconAverage Volume0.49M
iconDividend Yield--
iconP/E Ratio21.333
What does the G1 Therapeutics Inc do?
N/A
Read More
How much money does G1 Therapeutics Inc make?
News & Events about G1 Therapeutics Inc.
Globe Newswire
22days ago
RESEARCH TRIANGLE PARK, N.C., Jan. 11, 2023 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (Nasdaq: GTHX), a commercial-stage oncology company, today announced that on January 19th, 2023, at 11:30 AM EST, G1s Chief Executive Officer Jack Bailey will provide a corporate presentation during the virtual ...
Globe Newswire
2 months ago
RESEARCH TRIANGLE PARK, N.C., Dec. 01, 2022 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (Nasdaq: GTHX), a commercial-stage oncology company, today announced the grant of inducement stock options exercisable for 14,400 shares of G1s common stock and 9,400 restricted stock units (RSUs) to five hired ...
PR Newswire
2 months ago
Big Developments Set to be Unveiled at This Year's San Antonio Breast Cancer Symposium (SABCS) Big Developments Set to be Unveiled at This Year's San Antonio Breast Cancer Symposium (SABCS) PR Newswire VANCOUVER, British Colombia, Nov. 30, 2022 FN Media Group Presents USA News Group News Commentary...
Zolmax
2 months ago
G1 Therapeutics (NASDAQ:GTHX Get Rating) had its target price cut by investment analysts at HC Wainwright from $57.00 to $34.00 in a research note issued to investors on Wednesday, The Fly reports. HC Wainwrights price objective points to a potential upside of 455.56% from the stocks previous close...
Ticker Report
2 months ago
G1 Therapeutics (NASDAQ:GTHX Get Rating) had its price objective cut by HC Wainwright from $57.00 to $34.00 in a research note issued on Wednesday, The Fly reports. HC Wainwrights price target points to a potential upside of 455.56% from the stocks previous close. GTHX has been...
Frequently Asked Questions
Frequently Asked Questions
What is G1 Therapeutics Inc share price today?
plus_minus_icon
Can Indians buy G1 Therapeutics Inc shares?
plus_minus_icon
How can I buy G1 Therapeutics Inc shares from India?
plus_minus_icon
Can Fractional shares of G1 Therapeutics Inc be purchased?
plus_minus_icon
What are the documents required to start investing in G1 Therapeutics Inc stocks?
plus_minus_icon
What is today’s traded volume of G1 Therapeutics Inc?
plus_minus_icon
What is today’s market capitalisation of G1 Therapeutics Inc?
plus_minus_icon
What is the 52-Week High and Low Range of G1 Therapeutics Inc?
plus_minus_icon
What percentage is G1 Therapeutics Inc down from its 52-Week High?
plus_minus_icon
What percentage is G1 Therapeutics Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$0
$0.19
(2.33%)
logo-gthx
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00